Sales of pain drugs "to rise 1.8%/year to 2026"

Sales of pain drugs "to rise 1.8%/year to 2026"
In contrast, European physicians are more likely to prescribe the dual-acting opioid analgesic tramadol to a greater percentage of their acute pain patients than their colleagues in the US and Japan, while Japanese physicians more frequently rely on …

Full News here – Read more on PharmaTimes

Leave a Reply